Verrica Pharmaceuticals Inc. (VRCA) › Cost of RevenueVerrica Pharmaceuticals Inc. (VRCA) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2023: $500.0K2024: $2.60M$2.60M2023Cost of Revenue (USD)2024Fiscal YearCost of RevenueChange YoY2024$2.60M+420.0%2023$500.0K—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share